Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.74 |
| ▸ | AGXT | P21549 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.52 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | MAOA | P21397 | 4/20 | 0.48 |
| ▸ | MAOB | P27338 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3075866 | 0.97 | IDO1 (0.71) | IDO1AGXTCA1CA2CA9 | |
| SCHEMBL1520805 | 0.85 | IDO1 (1.00) | IDO1AGXTSMN1; SMN2CYP2A6HTR2A | |
| SCHEMBL2146745 | 0.83 | IDO1 (0.87) | IDO1AGXTHTR2AMAOAMAOB | |
| Hydrochloric Acid SCHEMBL1715614 | 0.83 | IDO1 (0.95) | IDO1AGXTSMN1; SMN2CYP2A6HTR2A | |
| Hydrochloric Acid SCHEMBL8978658 | 0.81 | IDO1 (0.83) | IDO1AGXTHTR2AMAOAMAOB | |
| SCHEMBL8193806 | 0.81 | IDO1 (0.83) | IDO1HTR2AMAOAMAOBLMNA | |
| SCHEMBL8815963 | 0.81 | IDO1 (0.83) | IDO1HTR2AMAOAMAOBLMNA | |
| Hydroxyamine SCHEMBL8543884 | 0.78 | IDO1 (0.77) | IDO1AGXTHTR2AMAOAMAOB | |
| SCHEMBL198134 | 0.78 | TSHR (0.52) | IDO1CA1CA2CA9SMN1; SMN2 | |
| SCHEMBL6341147 | 0.78 | ALDH1A1 (0.52) | IDO1CA1CA2CA9SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 242 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119118850-A | Method for preparing amino phenethyl alcohol compound by reforming indole compound structure | 中国科学院兰州化学物理研究所 | 2024-12-13 | — | — | CN | claimed |
| CN-116676354-A | Method for synthesizing indigo and derivative thereof through double-enzyme cascade catalysis | 南京工业大学 | 2023-09-01 | — | — | CN | claimed |
| EP-4126895-A1 | METHOD FOR PREPARING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE-5'-TRIPHOSPHATES | DNA Script (FR) | 2023-02-08 | — | — | EP | claimed |
| CN-115362161-A | Process for preparing 3' -O-amino-2 ' -deoxyribonucleoside-5 ' -triphosphates | DNA斯克瑞普特公司 | 2022-11-18 | — | — | CN | claimed |
| CN-109912434-B | Synthesis method of phenylethanolamine beta receptor agonist | 上海安谱实验科技股份有限公司 | 2022-07-12 | — | — | CN | claimed |
| WO-2021198040-A1 | METHOD FOR PREPARING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE-5'-TRIPHOSPHATES. | DNA SCRIPT (FR) | 2021-10-07 | — | — | WO | claimed |
| US-20210300961-A1 | METHOD FOR PREPARING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE-5'-TRIPHOSPHATES | DNA SCRIPT SAS (FR) | 2021-09-30 | — | — | US | claimed |
| CN-113402403-A | Preparation process of o-aminophenyl ethyl ether | 江苏普洛德化学科技有限公司 | 2021-09-17 | — | — | CN | claimed |
| CN-102464305-A | Multi-metal chalcogenide and preparation method thereof | HELIOHAWK OPTOELECTRONICS CORP | 2012-05-23 | — | — | CN | claimed |
| EP-2170869-A1 | ALCOHOLS CONTAINING IMIDE MOIETIES AND REACTIVE OLIGOMERS PREPARED THEREFROM | Henkel AG & Co. KGaA (DE) | 2010-04-07 | — | — | EP | claimed |
| CN-1219926-A | Phenethanolamino-1, 2,3, 4-tetrahydronaphthalenyloxyalkyl amide derivatives | KISSEI PHARMACEUTICAL (JP) | 1999-06-16 | — | — | CN | claimed |
| CN-1216526-A | 3,4-disubstituted phenylethanolaminotetra lincarboxamide derivatives | KISSEI PHARMACEUTICAL (JP) | 1999-05-12 | — | — | CN | claimed |
| US-5495031-A | Process for the production of 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines | AMERICAN CYANAMID COMPANY (US) | 1996-02-27 | — | — | US | claimed |
| US-5495032-A | AMINATION OF THE CORRESPONDING HALOGEN CONTAINING COMPOUND | AMERICAN CYANAMID COMPANY (US) | 1996-02-27 | — | — | US | claimed |
| US-5466684-A | 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines | AMERICAN CYANAMID COMPANY (US) | 1995-11-14 | — | — | US | claimed |
| US-5457096-A | Antibiotic | AMERICAN CYANAMID COMPANY (US) | 1995-10-10 | — | — | US | claimed |
| US-5420272-A | 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines | AMERICAN CYANAMID COMPANY (US) | 1995-05-30 | — | — | US | claimed |
| US-5371076-A | ANTIBIOTICS | AMERICAN CYANAMID COMPANY (US) | 1994-12-06 | — | — | US | claimed |
| US-5328902-A | Antibiotics | AMERICAN CYANAMID CO. (US) | 1994-07-12 | — | — | US | claimed |
| US-3984472-A | Preparation of N,N-dialkyl p-vinyl anilines | POLAROID CORPORATION (US) | 1976-10-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210300961-A1 | METHOD FOR PREPARING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE-5'-TRIPHOSPHATES | DUT, RNMT, NUDT1 | IDO1 997/4885AGXT 971/4885CA1 4810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.